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Abstract
Background: The current practice in newborn medicine is to subjectively assess when a premature infant is ready to feed by
mouth. When the assessment is inaccurate, the resulting feeding morbidities may be significant, resulting in long-term
health consequences and millions of health care dollars annually. We hypothesized that the developmental maturation of
hypothalamic regulation of feeding behavior is a predictor of successful oral feeding in the premature infant. To test this
hypothesis, we analyzed the gene expression of neuropeptide Y2 receptor (NPY2R), a known hypothalamic regulator of
feeding behavior, in neonatal saliva to determine its role as a biomarker in predicting oral feeding success in the neonate.
Methodology/Principal Findings: Salivary samples (n=116), were prospectively collected from 63 preterm and 13 term
neonates (post-conceptual age (PCA) 26 4/7 to 41 4/7 weeks) from five predefined feeding stages. Expression of NPY2R in
neonatal saliva was determined by multiplex RT-qPCR amplification. Expression results were retrospectively correlated with
feeding status at time of sample collection. Statistical analysis revealed that expression of NPY2R had a 95% positive
predictive value for feeding immaturity. NPY2R expression statistically significantly decreased with advancing PCA (Wilcoxon
test p value,0.01), and was associated with feeding status (chi square p value = 0.013).
Conclusions/Significance: Developmental maturation of hypothalamic regulation of feeding behavior is an essential
component of oral feeding success in the newborn. NPY2R expression in neonatal saliva is predictive of an immature
feeding pattern. It is a clinically relevant biomarker that may be monitored in saliva to improve clinical care and reduce
significant feeding-associated morbidities that affect the premature neonate.
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Introduction
The current practice in newborn intensive care units is to have
caregivers subjectively assess when a premature infant is ready to
feed by mouth. When the assessment is inaccurate, morbidities
may include choking, hypoxia, aspiration, oral aversion, and
prolonged hospitalization [1–3]. These associated morbidities are
estimated to cost millions of U.S. health care dollars annually. A
barrier to the development of an objective diagnostic assay is the
ability to directly assess the complex neuromuscular and neuro-
logical sequences required for the development of safe and
effective oral feeding skills in the premature neonate [4–6].
Furthermore, feeding behavior is the result of a complex interplay
of feedback loops, satiety, and cellular signaling that is under the
direct control of the hypothalamus [7,8]. While hypothalamic
regulation of feeding behavior is an area of active investigation,
such research has frequently been conducted on genetically altered
animal models with post-mortem examinations to allow for direct
visualization and staining of the hypothalamus and its associated
neurological pathways [9–12].
Neuropeptide Y (NPY) and its family of five receptors are known
to be associated with hypothalamic regulation of feeding behavior,
metabolism, and energy homeostasis in both rodents and humans
[9–12]. In particular, knock-out mice for the gene neuropeptide Y
2 receptor, NPY2R, exhibit hyperphagia and excessive weight gain
[9]. As a result, research on the gene has focused on genotyping
analysis for the identification of single nucleotide polymorphisms
(SNPs) in obese human subjects [13,14] and drug development for
manipulation of its expression as a novel therapeutic treatment for
obesity [15,16]. Although primarily expressed in the arcuate
nucleus of the hypothalamus [17], NPY2R may also be found in
other tissues including trabecular bone [18], vascular tissue [19],
and colonic mucosa [20].
Previously, our laboratory published on the diverse range of
gene expression changes occurring in the premature neonate that
can be detected in as little as 10 mL of saliva. Specifically, we
showed that expression of NPY2R in neonatal saliva statistically
significantly changed over time as newborns learned to orally feed
[21]. This work suggested that the hypothalamus plays a central
role in feeding behavior in the premature neonate. Further,
through noninvasive salivary gene expression analyses, we can
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to the learning process of oral feeding. Here, we hypothesized that
the physiological hyperphagia and exponential weight gain
observed in healthy term newborns is associated with decreased
expression of NPY2R. Persistence of NYP2R in salivary samples
would suggest immature hypothalamic regulation, indicative of
failed oral feeding trials. In this study, we independently explored
NPY2R’s expression profile in relation to feeding status and post-
conceptual age (PCA), and determined its role as a biomarker in
neonatal saliva to objectively predict successful oral feeding in the
newborn.
Results
Demographics and Sample Characteristics
One hundred and sixteen salivary samples (10 to 50 mL) were
collected from 76 newborns with post-conceptual ages (PCAs)
ranging from 26 4/7 to 41 4/7 weeks. There were 63 preterm and
13 term infants in this data set. Pertinent clinical information for
all subjects is shown in Table 1, while a detailed summary of
clinical sequelae for each individual subject is available in Table
S1. In general, subjects in the study were either healthy term
newborns, or premature infants who had resolution of their acute
clinical sequelae and were ‘‘feeders and growers’’ in the NICU
prior to discharge home. Of the 76 subjects enrolled in this study,
31 had between two and five salivary samples analyzed, at either
different PCAs and/or feeding statuses. The number of samples
collected from subjects at each predefined feeding stage, as well as
the percentage of infants expressing NPY2R, was as follows: Stage
1: no feeds (NPO) (n=17; PCA 25 3/7 to 36 1/7 weeks; 59%
NPY2R expression); Stage 2: partial per gastric feeds (PPG) (n=21,
PCA 28 2/7 to 41 3/7 weeks; 57% NPY2R expression); Stage 3:
full per gastric feeds (FPG) (n=36, PCA 28 5/7 to 37 5/7 weeks;
67% NPY2R expression); Stage 4: partial oral feeds (PPO) (n= 24,
PCA 33 5/7 to 41 2/7 weeks; 50% NPY2R expression); Stage 5:
full oral feeds (FPO) (n=18, PCA 33 3/7 to 40 2/7 weeks; 17%
NPY2R expression).
Multiplex Reverse Transcription-quantitative Polymerase
Chain Reaction (RT-qPCR) Characteristics
Every effort was made to adhere to the Minimum Information
for Publication of Quantitative Real-Time PCR Experiments
(MIQE) guidelines [22]. Multiplex RT-qPCR amplification was
performed on all extracted total RNA samples for the gene
NPY2R, along with three reference genes: glyceraldehyde-3-
phosphate dehydrogenase (GAPDH), tyrosine 3-monoxygenase/
tryptophan 5-monooxygenase activation protein, zeta polypeptide
(YWHAZ), and hypoxanthine phosphoribosyltransferase 1
(HPRT1). Reference genes were selected based upon microarray
data from previous studies conducted in our laboratory that
revealed that each of these genes maintains a relative constant and
consistent range of expression across different PCAs. We selected
one gene known to be expressed at a relatively high level
(YWHAZ), one that had an average expression level (GAPDH), and
one that demonstrated a low level of expression (HPRT1) at the
limit of our detection level on the multiplex platform.
Prior to multiplex RT-qPCR, three samples were tested
simultaneously on both uniplex and multiplex platforms for all
genes to assess reaction efficiencies. There was no difference in
reaction efficiency between uniplex and multiplex assays. Of the
three test samples run in both formats, quantification cycle (Cq)
values were within 1 cycle for all genes. Thus, we were confident
that running the samples on a multiplex platform would not
impact results. The reference gene YWHAZ had the highest level
of expression in our samples (mean Cq: 27.7), followed by GAPDH
(mean Cq: 30.3), and HPRT1 (mean Cq: 36.8). Mean delta Cq and
standard deviation values between reference genes for all reactions
were as follows: GAPDH-YWHAZ: 2.3+/21.85; HPRT1-GAPDH
7.2+/21.83; HPRT1-YWHAZ 9.5+/21.93. These results demon-
strate that reaction efficiencies across experiments were similar
and reproducible. Of the 116 samples analyzed, 95 had
amplification of all three reference genes, while 21 revealed
amplification of GAPDH, and YWHAZ only. Of these 21 samples,
six were positive for NPY2R expression and 15 had no detectable
NPY2R in the sample.
Assay Results
For the purpose of this study, we performed three separate
statistical analyses on the data. The first analysis considered all 116
data points; the second analysis considered only one sample per
subject in order to ensure that multiple sampling from an
individual was not skewing the data (n=76); the third analysis
removed samples that did not have amplification of all three
housekeeping genes in order to eliminate those samples that had a
theoretical risk of a false negative result (n=95). NPY2R expression
in neonatal saliva for all 116 samples had a 95% positive predictive
value (CI: 85%–99%) of an immature feeding pattern with an
inability to sustain full oral feeds (Stage 5). The negative predictive
value of the assay was 27% (CI: 17%–41%). The sensitivity was
59% (CI: 49%–69%) with 83% specificity (CI: 58%–96%). There
was a statistically significant difference between NPY2R expression
and PCA. Neonates who expressed NPY2R were younger than
those infants who did not express the gene (p value,0.01)
(Figure 1). However, among term infants, there was a statistically
significant difference between infants who could and could not
orally feed (p value = 0.037) (Figure 2). Expression of NPY2R was
associated with feeding status (p value = 0.013) (Figure 3). As
infants matured through the feeding stages, they were less likely to
express the gene.
Neither of the two additional statistical analyses altered our
primary results. Limiting the data set to include only one salivary
sample per subject revealed a positive predictive value of 97% (CI:
85%–100%), with a negative predictive value of 38% (CI: 23%–
55%). Sensitivity of the assay was 62% (CI: 50%–75%) with
specificity of 93% (CI: 66%–100%). NPY2R expression remained
statistically significantly associated with advancing PCA (Wilcoxon
rank sum test p value,0.01) and feeding status (chi square p value
= 0.004). Further, eliminating the samples that did not have
amplification of all three housekeeping genes in order to reduce
the potential impact of false negative results had a positive
predictive value of 95% (CI: 84%–99%), negative predictive value
of 33% (CI:20%–50%), with a sensitivity of 67% (CI: 55%–77%)
and specificity of 81% (51%–95%). NPY2R expression was
marginally statistically significantly associated with advancing
PCA (Fisher’s exact test p value = 0.054). There remained a
nonrandom association between NPY2R expression and feeding
status (chi square p value = 0.076).
Discussion
Our results demonstrate that detection of NPY2R in neonatal
saliva has a 95% positive predictive value for determining that an
infant cannot sustain full oral feeds, implying that this gene plays
an important role in neonatal feeding behavior. Our data suggest
that NPY2R is a novel biomarker that could be used as part of an
objective assay prior to the introduction of oral feeds, particularly
for those infants at risk for aspiration, hypoxia, and long-term
feeding aversion.
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influences neonatal feeding are currently unknown, our data
demonstrate that expression of NPY2R is independent of the
presence of enteral nutrition if given by catheter. We were only
able to detect down-regulation of the gene once infants were able
to take at least some feeds by mouth. Thus, stimulation of the
gastrointestinal tract alone is not enough to cause decreased gene
expression. Similarly, although NPY2R expression is statistically
significantly negatively correlated with advancing PCA, here too, it
appears that the PCA of the infant is not the sole driving force
behind NPY2R expression. Some subjects in this study could
successfully orally feed prior to 34 weeks’ PCA, while others at 41
weeks’ PCA could not. In fact, there was a statistically significant
difference in NPY2R expression between infants who could and
could not orally feed at term gestation. Thus, while advancing
gestational age correlates with decreased NPY2R expression, the
relationship is complex and not mutually inclusive. Of note,
neonates in this study had a wide range of ages and clinical
sequelae. The deliberate incorporation of a diverse patient
population was essential to determine the applicability and
accuracy of NPY2R as a diagnostic salivary biomarker.
We believe that NPY2R’s relatively weak negative predictive
power confirms the complexities of oral feeding in the newborn.
The physical limitations of some infants, including lung disease,
reliance on oxygen and poor gastrointestinal motility, may
prohibit neonates from sustaining oral feeds who otherwise appear
to have appropriate hypothalamic signaling. In addition, subjec-
tive assessments by the caregivers that infants could not safely feed
and therefore did not allow the neonates to attempt oral feeds may
have skewed the data. Thus, future work must be performed to
identify additional biomarkers in neonatal saliva that will
incorporate all aspects of feeding in the neonate, including
maturation of oral musculature and innervation.
The potential to monitor hypothalamic regulation of feeding
behavior through salivary gene expression analysis is also a major
Table 1. Pertinent Clinical and Demographic Information.
Feeding Stage Number of Subjects PCA (weeks) Weight (kg) Summarized Medical Complications of Subjects
1 (NPO) 17 25 3/7–36 1/7 0.73–2.136 Respiratory distress syndrome (RDS), patent ductus
arteriosus (PDA), intrauterine growth restriction (IUGR),
bronchopulmonary dysplasia (BPD), urinary tract
infection (UTI), neonatal abstinence syndrome (NAS),
pulmonary valvular stenosis, apnea, hyperbilirubinemia,
ABO incompatibility, anemia, anal fissure, choanal
atresia, leukocytosis, metabolic acidosis, undescended
testicle, multiple gestation
2 (PPG) 21 28 2/7–41 3/7 0.78–3.845 RDS, PDA, BPD, IUGR, apnea, anemia, thrombocytopenia,
coagulopathy, hyperbilirubinemia, ABO incompatibility,
transient tachypnea, multiple gestation, bacteremia,
persistent pulmonary hypertension (PPHN), metabolic
acidosis
3 (FPG) 36 28 5/7–37 5/7 0.911–2.215 RDS, IUGR, BPD, right grade I intraventricular
hemorrhage (IVH), leukocytosis, acidosis, neutropenia,
peripheral pulmonary stenosis, transient tachypnea,
multiple gestation, narcotic exposure, bacteremia,
polydactyly
4 (PPO) 24 33 5/7–41 2/7 1.445–3.678 RDS, NAS, IUGR, small for gestational age (SGA), anemia,
apnea, hypertension, hemangioma, hyperbilirubinemia,
multiple gestation, twin-to-twin transfusion,
thrombocytopenia, anal fissure, membranous choanal
atresia, hypermagnesia
5 (FPO) 18 33 3/7–40 2/7 1.807–3.910 Hyperbilirubinemia, ABO incompatibility, RDS, BPD
doi:10.1371/journal.pone.0037870.t001
Figure 1. NPY2R gene expression and advancing post-concep-
tual age in weeks (all infants).
doi:10.1371/journal.pone.0037870.g001
Figure 2. NPY2R gene expression and feeding status in term
infants.
doi:10.1371/journal.pone.0037870.g002
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be obtained noninvasively, in as little as 10 ml of saliva, from
human subjects. We speculate that our ability to readily detect
NPY2R in neonatal saliva is a direct result of the permeability of
the arcuate nucleus to the blood brain barrier [17]. As a filtrate of
blood, saliva has been called a ‘window into the body’ with a
biomarker profile similar to plasma [23].
The analysis of NPY2R gene expression as it relates to oral
feeding in the premature neonate provides a window into
developmental biology that has the potential to transcend into
other areas of medicine. The early newborn period represents a
unique time in the human lifespan when hyperphagia and
exponential weight gain is normal. The average newborn will
gain 200% of his or her birth weight by one year of age. Our
results suggest that developmentally, the human neonate down-
regulates NPY2R expression in order to demonstrate the necessary
hyperphagia required for this exponential growth. We speculate
that understanding the normal developmental expression of the
gene, combined with its ease of monitoring in human saliva, has
the potential to help elucidate pathological conditions, including
obesity.
Previous studies on neonatal oral feeding almost exclusively
focused on oral motor skills, the suck-swallow reflex, neurodevel-
opment and neuronal integration [4,5]. Here, we speculate that in
addition to these essential developmental milestones, satiety, as
regulated, in part, by NPY2R expression, also plays a key role in
oral feeding success. This is based both upon the numerous
published reports linking NPY2R expression with hunger, satiety
and feeding behavior in both humans and animals [9–14], and our
previous work on the neonatal salivary transcriptome demonstrat-
ing that NPY2R had statistically significantly gene expression
changes over time as infants matured and learned to orally feed
[21]. By demonstrating that detection of NPY2R in neonatal saliva
is predictive of failed oral feeding trials, we have substantiated our
hypothesis that NPY2R does play a role in the attainment of
successful newborn oral feeding.
In conclusion, NPY2R is a predictive novel biomarker in
neonatal saliva that may be monitored noninvasively in order to
objectively determine when an infant can safely feed by mouth.
While future research is needed to further elucidate the precise
molecular role of NPY2R in relation to human newborn feeding, its
presence in neonatal saliva nevertheless remains 95% predictive of
an immature feeding pattern and an inability to sustain full oral
feeds. This work lays the foundation for the development of an
objective diagnostic test to accurately and safely predict oral
readiness to feed in this vulnerable population, significantly
improving clinical care, and reducing millions of dollars of health
care costs associated with feeding morbidities in the premature
neonatal population.
Materials and Methods
Ethics Statement
This study was approved by the Tufts Medical Center
Institutional Review Board. Written parental consent was
obtained for all neonatal subjects enrolled.
Demographics and Sample Characteristics
Salivary samples were collected from premature and term
neonates with a diverse range of clinical sequelae at various
feeding stages during hospitalization: Stage 1: no feeds (NPO);
Stage 2: partial gastric feedings (PPG); Stage 3: full gastric feedings
(FPG); Stage 4: partial oral feeds (PPO); Stage 5: full oral feeds
(FPO). Infant feeding stage at time of collection was determined
solely by the caregivers and was not influenced by study
participation. The number of samples collected from a subject
was dependent upon their clinical course. In general, premature
infants had more than one salivary sample obtained as they
matured through the feeding process, while healthy term infants
had only one sample obtained at feeding stage 5, FPO. Although
salivary samples were collected prospectively from all enrolled
subjects, the correlation between salivary NPY2R gene expression
and feeding status was made retrospectively once all samples were
obtained and analyzed.
Salivary Collection and mRNA Extraction
All salivary samples were collected and processed with
previously described standardized techniques that aim to simulate
routine bedside care of the neonates [24]. Samples were stored at
4uC for a minimum of 48 hours prior to total RNA extraction with
the use of the RNA Protect Saliva Mini Kit (Qiagen, Valencia, CA
USA) per manufacturer’s instructions. On column DNase
digestion was performed on all samples to limit DNA contami-
nation. Final elution volume was approximately 14 mL. Samples
were stored at 280uC pending further analysis.
Multiplex qRT-PCR
All RT-qPCR experiments were performed on the Life
Technologies 7900 instrument with the use of the Path-ID
TM
Multiplex One-Step RT-PCR Kit (Life Technologies, Carlsbad,
CA USA). Standard stock sequences of reference genes were
provided by Life Technologies and were VIC labeled, primer
limited. They were as follows: GAPDH-VIC (Hs03929097),
HPRT1-VIC (Hs01003267), and YWHAZ-VIC (Hs03044281).
Gene sequences for NPY2R were custom made with the use of
Primer Express Software v 1 to ensure optimal G-C content and
melting temperatures. The custom sequence for NPY2R (Sequence
accession number: NM_000910.2) was as follows: Forward
Primer: GGC TTT CCT CTC GGC CTT C; Reverse Primer
TGT CAC GGA CAC CTC AGA GTG; Probe 6FAM-CTG
TGA GCA GCG GTT GGA TGC CAT-TAMRA. The
amplicon is located at base pairs 1496 to 1563 of the gene and
to the best of our knowledge, contains no SNPs. There are only
two known exons for the gene NPY2R. The entire amplicon used
in this study was contained within one exon.
For each salivary sample, NPY2R was run in triplicate,
multiplexed one time each with the three reference genes.
Negative controls with nuclease-free water were performed on
each plate. The total volume for each reaction was 25 mL
including 2.5 mL of template in each well. The thermal cycle
profile for all reactions was as follows: 48uC for 10 minutes, 95uC
Figure 3. NPY2R gene expression and feeding status (all
infants).
doi:10.1371/journal.pone.0037870.g003
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denaturing cycle at 95uC, followed by 45 seconds of annealing and
extension at 60uC.
For the purposes of this study, only the expression of NPY2R in
neonatal saliva was considered. The gene was considered
expressed if it amplified along with $2 of the reference genes.
Similarly, NPY2R was considered not expressed if it did not
amplify in the presence of $2 of the reference genes. Lacking any
reference values for salivary NPY2R, it is difficult to provide a
clinical interpretation based upon normalized relative quantitative
values. Therefore, we analyzed the data in the context of
expression of the gene in order to provide our most accurate
and biologically relevant assessment. The binary nature of the
assay makes it well suited for the development of a rapid diagnostic
assay. Finally, average Cq for each reference gene was calculated,
along with mean delta Cq and standard deviation values between
housekeeping genes to assess efficiencies and variability between
reactions.
Statistical Analyses
Statistical analyses included the Fisher’s exact test to determine
the relationship of NPY2R expression and gestational age, as well
as a Wilcoxon rank sum test to compare gestational age in the
groups of infants that did or did not express NPY2R (Figure 1).
Chi-square test was used to assess the association between NPY2R
gene expression and feeding status (Stages 1–5) (Figure 3). We
further examined NPY2R expression at term gestation ($37 weeks’
gestation) with the use of a Fisher’s exact test to compare
expression of the gene in saliva between infants who could and
could not successfully feed (Figure 2). Sensitivity, specificity,
negative and positive predictive values, along with each respective
confidence interval, of the assay were then calculated. Additional
statistical analyses were performed to (1) limit the analysis to those
samples that had amplification of all three reference genes and to
(2) ensure that repeat measures from the same individuals in this
study did not skew the data. In the latter analysis, we used only one
sample per infant, determined by a random computer number
generator to reduce the risk of bias.
Supporting Information
Table S1 Complete subject demographic and clinical
information.
(XLSX)
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